Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.

about

Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.Multiparametric High-Resolution MRI as a Tool for Mapping of Hypoxic Level in Tumors

P2860

Q38626024-A8F4FE6D-F76C-46C0-BFCB-326ABC434306 Q57182090-5EE5AFC4-4567-4141-B997-158750FB1797

P2860

Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.

Item

http://www.wikidata.org/entity/Q53829611

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@en

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@nl

type

Item

label

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@en

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@nl

prefLabel

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@en

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@nl

P1476

Multiparametric MRI as an earl ...... nt treatment of brain tumours.

@en

P2093

Audrey Bouchet

http://www.w3.org/2001/XMLSchema#string

Chantal Rémy

http://www.w3.org/2001/XMLSchema#string

Cécile Maisin

http://www.w3.org/2001/XMLSchema#string

Géraldine Le Duc

http://www.w3.org/2001/XMLSchema#string

Thomas Christen

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Malignant gliomas in adults

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Vessel size imaging.

Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T(1), T(2), T*(2), and non-Lorentzian signal behavior.

Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.

P304

1163-1173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NBM.3357

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin Lemasson

Emmanuel L Barbier

Raphael Serduc

P577

2015-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280585328

http://www.w3.org/2001/XMLSchema#string

P698

26224287

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.

about

P2860

P2860

Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921